PGK1, as an important enzyme in glycolytic pathways, had obvious influence on breast cancer patients’ clinical outcome, which revealed that PGK1 played a critical role in the progression of breast cancer and may be a potential therapeutic target. Here, PGK1 is linked to breast carcinoma.